In silico analysis of missense substitutions using sequence‐alignment based methods
暂无分享,去创建一个
[1] Alun Thomas,et al. Classification of rare missense substitutions, using risk surfaces, with genetic‐ and molecular‐epidemiology applications , 2008, Human mutation.
[2] Paolo Boffetta,et al. Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group , 2008, Human mutation.
[3] N. de Wind,et al. Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance , 2008, Human mutation.
[4] Douglas F Easton,et al. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.
[5] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[6] A. Löytynoja,et al. Phylogeny-Aware Gap Placement Prevents Errors in Sequence Alignment and Evolutionary Analysis , 2008, Science.
[7] Stephen B Gruber,et al. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR) , 2008, Human mutation.
[8] Sue Healey,et al. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] H. Campbell,et al. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population‐based study of colorectal cancer , 2008, Human mutation.
[10] M. Suchard,et al. Alignment Uncertainty and Genomic Analysis , 2008, Science.
[11] E. Capriotti,et al. Use of estimated evolutionary strength at the codon level improves the prediction of disease‐related protein mutations in humans , 2008, Human mutation.
[12] Fergus J Couch,et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.
[13] L. Serrano,et al. Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. , 2007, American journal of human genetics.
[14] P. Lockhart,et al. A reality check for alignments and trees. , 2007, Trends in genetics : TIG.
[15] Andrew J. Grimm,et al. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR) , 2007, Human mutation.
[16] Joost Schymkowitz,et al. The stability effects of protein mutations appear to be universally distributed. , 2007, Journal of molecular biology.
[17] Shamil R Sunyaev,et al. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.
[18] Andrew J. Bulpitt,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btl649 Genome analysis Deleterious SNP prediction: be mindful of your training data! , 2022 .
[19] Andrej Sali,et al. Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning , 2006, PLoS Comput. Biol..
[20] J. Hopper,et al. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. , 2006, Cancer research.
[21] A. Zharkikh,et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.
[22] J. Hopper,et al. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants , 2005, Journal of Medical Genetics.
[23] Peng Yue,et al. SNPs3D: Candidate gene and SNP selection for association studies , 2006, BMC Bioinformatics.
[24] B. Ward,et al. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. , 2005, Cancer research.
[25] J. Moult,et al. Loss of protein structure stability as a major causative factor in monogenic disease. , 2005, Journal of molecular biology.
[26] A. de la Chapelle,et al. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. , 2005, Gastroenterology.
[27] Modesto Orozco,et al. PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..
[28] A. Sidow,et al. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. , 2005, Genome research.
[29] M. Gerstein,et al. Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms , 2005, Nucleic acids research.
[30] M. Orozco,et al. Sequence‐based prediction of pathological mutations , 2004, Proteins.
[31] P. Thomas,et al. Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] F. Couch,et al. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. , 2004, American journal of human genetics.
[33] A. Zharkikh,et al. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation , 2004, Journal of Medical Genetics.
[34] Nebojsa Mirkovic,et al. Structure-Based Assessment of Missense Mutations in Human BRCA1 , 2004, Cancer Research.
[35] Jotun Hein,et al. A nucleotide substitution model with nearest-neighbour interactions , 2004, ISMB/ECCB.
[36] C. Sander,et al. The amino-acid mutational spectrum of human genetic disease , 2003, Genome Biology.
[37] M. Campbell,et al. PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.
[38] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[39] S. Batzoglou,et al. Quantitative estimates of sequence divergence for comparative analyses of mammalian genomes. , 2003, Genome research.
[40] J. Bond,et al. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants , 2003, Oncogene.
[41] P. Bork,et al. Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.
[42] M. Orozco,et al. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. , 2002, Journal of molecular biology.
[43] L. Cannon-Albright,et al. Characterization of common BRCA1 and BRCA2 variants. , 2002, Genetic testing.
[44] M. Miller,et al. Understanding human disease mutations through the use of interspecific genetic variation. , 2001, Human molecular genetics.
[45] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[46] J. Moult,et al. SNPs, protein structure, and disease , 2001, Human mutation.
[47] Warren C. Lathe,et al. Prediction of deleterious human alleles. , 2001, Human molecular genetics.
[48] Wojciech Makalowski,et al. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features , 1999, Oncogene.
[49] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. O. Dayhoff,et al. 22 A Model of Evolutionary Change in Proteins , 1978 .
[51] R. Grantham. Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.
[52] J. L. King,et al. Deleterious Mutations and Neutral Substitutions , 1971, Nature.
[53] L. Pauling,et al. Molecules as documents of evolutionary history. , 1965, Journal of theoretical biology.